摘要:
A compartment latch is shown. It includes a fork bolt that moves between an open position and a closed position and a first detent lever that that cooperates with the fork bolt and that moves between a latched position and a released position. A support for holding the fork bolt and the detent lever is also provided. A second detent lever for biasing against the first detent lever when the first detent lever is in the released position is provided. The second detent lever is connected to the support at a hinge.
摘要:
A compartment latch is shown. It includes a fork bolt that moves between an open position and a closed position and a first detent lever that that cooperates with the fork bolt and that moves between a latched position and a released position. A support for holding the fork bolt and the detent lever is also provided. A second detent lever for biasing against the first detent lever when the first detent lever is in the released position is provided. The second detent lever is connected to the support at a hinge.
摘要:
An actuator for a latch is provided, the actuator having: a motor operatively coupled to a gear train; and a rack moveably mounted to the actuator for linear movement with respect to a housing of the actuator, wherein the gear train comprises: a worm; a worm gear and a pinion gear, wherein the pinion gear is rotatably mounted to the worm gear and the pinion gear has a plurality of teeth configured to engage a portion of the rack, wherein the axis of rotation of the worm is perpendicular to the axis of rotation of the worm gear and the pinion gear.
摘要:
An actuator for a latch is provided, the actuator having: a motor operatively coupled to a gear train; and a rack moveably mounted to the actuator for linear movement with respect to a housing of the actuator, wherein the gear train comprises: a worm; a worm gear and a pinion gear, wherein the pinion gear is rotatably mounted to the worm gear and the pinion gear has a plurality of teeth configured to engage a portion of the rack, wherein the axis of rotation of the worm is perpendicular to the axis of rotation of the worm gear and the pinion gear and wherein the rack is configured to operatively couple the gear train to a locking lever of the latch and the rack also has a cam surface configured to actuate a switch as the rack is moved by the gear train.
摘要:
The present disclosure concerns the use of peptides and compositions, such as pharmaceutical compositions, to influence angiogenesis. Particular methods are useful for promoting angiogenesis, while others are particularly useful for inhibiting angiogenesis.
摘要:
A door latch comprising a forkbolt that has a movement between a latched position and an unlatched position is provided. A detent is included that has movement on a travel path between a first position and a second position, the detent engaging and holding the forkbolt in the latched position when the detent is in the first position. The detent releases the forkbolt for movement to the unlatched position when the detent moves to the second position. A detent spring eccentrically engages the detent relative to the detent travel path and biases the detent toward the first position. A release mechanism is also included for moving the detent against the bias of the detent spring to the second position, thus releasing the forkbolt and producing a non-linear torque on the detent.
摘要:
A door latch having a forkbolt that moves between a latched position and an unlatched position is provided. It includes a detent for holding the forkbolt in the latched position, and a power operated lock mechanism for moving the door latch to an unlock or lock position. It further comprises a first rotatable locking lever moveable between an unlocked and locked position and in operable communication with the detent through an intermittent lever; a second rotatable locking lever in operable communication with the first rotatable locking lever; a motor driven actuator engaging the second rotatable locking lever; and an actuator pin disposed between the motor driven actuator and the second rotatable locking lever for rotating the second rotatable locking lever.
摘要:
The present invention provides methods for the isolation, identification, and purification of adrenomedullin (AM)-binding proteins. Also, provided are methods for utilizing the purified AM-binding proteins, or functional portions thereof, to diagnose, treat, and monitor AM-related diseases, for example, diseases or disorders associated with abnormally elevated AM levels. In addition, the present invention provides a newly identified complex between AM and a specific AM-binding protein 1 (AMBP-1); which has been isolated and identified herein as factor H (fH). The invention also provides AM/AMBP complexes, particularly AM/FH complexes, and antibodies specifically reactive with this complexes. Further provided are methods for identifying and purifying complexes of AM and an AM binding protein using anti-AM/fH antibodies, and methods for treating conditions such as cancer or diabetes utilizing compositions comprising these antibodies. The present invention additionally provides methods for identifying antagonists agents that inhibit the function of AM, factor H, or the AM/factor H complex. The invention also provides methods for treating conditions such as cancer or diabetes using these antagonist agents.
摘要:
The methods of the present invention demonstrate that adrenomedullin (AM) is expressed in human cancer cell lines of diverse origin and functions as a universal autocrine growth factor driving neoplastic proliferation. The present invention provides for AM peptides and AM antibodies useful in therapeutic, pharmacologic and physiologic compositions. The present invention additionally provides for methods of diagnosis, treatment and prevention of disease utilizing compositions comprising the AM peptides and antibodies of the present invention. The methods of the present invention also provide for experimental models for use in identifying the role of AM in pancreatic physiology. The methods pertaining to rat isolated islets have show that AM inhibits insulin secretion in a dose-dependent manner. The monoclonal antibody MoAb-G6, which neutralizes AM bioactivity, was show by the methods of the present invention to increase insulin release fivefold, an effect that was reversed by the addition of synthetic AM.